This lecture will discuss the fundamental elements and utility of CCM™ therapy (cardiac contractility modulation) for patients that have heart failure and remain symptomatic despite guideline medical therapy. The Optimizer was designed to improve overall heart function and quality of life for patients. CCM™ indications will be discussed as well as best practices for screening patients for HCPs to offer this therapy for patients that qualify.

This lecture will discuss the device indications for CCM® Therapy and the importance of screening patients who are eligible to receive this device. Optimizer® is designed to improve overall heart function and quality of life for patients living with heart failure. The faculty will share their experiences and what they have learned about CCM® therapy and give case-based examples of how you can gain access to the therapy for your patients.

This webcast will cover the PAS objectives, endpoints, patient selection criteria, and follow-up testing requirements. Participants will receive a certificate of protocol training, in lieu of an in-person site initiation visit traditionally required prior to subject enrollment